Dose Response and Atypical Antipsychotics in Schizophrenia

By Kinon B.J.  

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 597-616

Adis International

Access to resources Recommend Favorite

A Critical Review of Rating Scales in the Assessment of Movement Disorders in Schizophrenia

By  

Current Drug Targets, Vol. 7, Iss. 9, 2006-09 ,pp. : 1225-1229

Bentham Science Publishers

Access to resources Recommend Favorite

Advantages of atypical antipsychotics in the maintenance treatment of schizophrenia

By Kissling W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 188-188

Elsevier

Access to resources Recommend Favorite

Impact of Atypical Antipsychotics on Quality of Life in Patients with Schizophrenia

By Awad A. George  

CNS Drugs, Vol. 18, Iss. 13, 2004-01 ,pp. : 877-893

Adis International

Access to resources Recommend Favorite

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

By Bhanji N.H.   Chouinard G.   Margolese H.C.  

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite